➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
McKinsey
Johnson and Johnson
Moodys
Baxter
Boehringer Ingelheim

Last Updated: January 27, 2021

DrugPatentWatch Database Preview

NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Norethindrone Acetate And Ethinyl Estradiol And Ferrous Fumarate, and what generic alternatives are available?

Norethindrone Acetate And Ethinyl Estradiol And Ferrous Fumarate is a drug marketed by Amneal Pharms, Glenmark Pharms Ltd, Mylan Labs Ltd, Xiromed, Apotex, and Barr Labs Inc. and is included in nine NDAs.

The generic ingredient in NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE is ethinyl estradiol; norethindrone acetate. There are twenty-six drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone acetate profile page.

Summary for NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE
US Patents:0
Applicants:6
NDAs:9
Suppliers / Packagers: 4
Formulation / Manufacturing:see details
DailyMed Link:NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE at DailyMed
Drug patent expirations by year for NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE

US Patents and Regulatory Information for NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amneal Pharms NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE ethinyl estradiol; norethindrone acetate TABLET, CHEWABLE;ORAL 207514-001 Sep 11, 2017 AB RX No No   Start Trial   Start Trial   Start Trial
Barr Labs Inc NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE ethinyl estradiol; norethindrone acetate TABLET;ORAL 090938-001 Dec 1, 2014 AB RX No No   Start Trial   Start Trial   Start Trial
Xiromed NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE ethinyl estradiol; norethindrone acetate TABLET, CHEWABLE;ORAL 209609-001 Jul 16, 2018 AB RX No No   Start Trial   Start Trial   Start Trial
Glenmark Pharms Ltd NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE ethinyl estradiol; norethindrone acetate TABLET;ORAL 204847-001 Nov 17, 2017 AB RX No No   Start Trial   Start Trial   Start Trial
Glenmark Pharms Ltd NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE ethinyl estradiol; norethindrone acetate TABLET, CHEWABLE;ORAL 210369-001 Dec 26, 2017 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Subscribe to access the full database, or Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Boehringer Ingelheim
Express Scripts
Medtronic
Dow
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2021 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2021 - 2022
 NCE-1 Patent Challenge Dates 2021 - 2022
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2021, www.DrugPatentWatch.com.

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group